Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Goodbody Health Ltd GDBYF

Goodbody Health Ltd is a wellness company operating in both COVID testing in the United Kingdom and as a vertically integrated cannabinoid CBD company that operates in the United Kingdom and the European Union. It has interests in COVID testing clinics, CBD extraction, wholesale bulk isolate, and distillate sales, retail CBD and white label sales, cannabinoid laboratory testing, and medicinal cannabis research programs.


GREY:GDBYF - Post by User

Comment by drmaddogs2on Jan 15, 2020 4:25am
51 Views
Post# 30554279

RE:RE:RE:ISCFA show the $6 million order to California BioScience

RE:RE:RE:ISCFA show the $6 million order to California BioScience
I've never understood that 'Honey' model of pricing, I surmise not being in retail is the reason. I would have thought Isolate would out price Honey.. maybe it is because Honey is more easily diluted? Anyway, the industry as a whole is still in expansion as to CBD commerce, could triple consumption once FDA in America and 'Foods' department in England get 'official guidance' and the triple will be inside a year imo. My opinion is that in 2020 we only have 3 real competitions from other producers, Charlotteweb(boy did they stick it to shareholders by selling all those shares last year), The aforementioned Mile High(which increased its debt load to 100 million last year and after Green Shoe period in going public investors will get a surprise... not a good one) and the third will be China... an ongoing mess of poor quality control issues. Fwiw, Stillcanna is still in a good position as to mass production capability once Horizon is built and that is what I'm 'investing in'.
<< Previous
Bullboard Posts
Next >>